About Dual AAV
Dual AAV vectors split your gene into two vectors that under in-vivo homologous recombination, reforms to produce a full gene product. These are used when payloads >4.7kb are required.
Dual AAV vector controls contain two AAV vectors, with each vector carrying half of a GFP reporter gene. When recombined, a functional GFP is formed, allowing quick visual read-out.
Your team can use dual AAV vector controls to de-risk projects, for proof-of-principle studies, and to optimize parameters before moving into larger, more complex experiments. These controls are available in a wide range of promoters for tissue targeting.
Features
· >95% Purity
· Low endotoxin (<0.3 EU/ml)
· Whole plasmid sequencing
· Dedicated technical support
Benefits
· Efficient delivery of large genes >4.7kb
· >95% Purity
· Low endotoxin (<0.3 EU/ml)
· Whole plasmid sequencing
· Dedicated technical support
Benefits
· Efficient delivery of large genes >4.7kb
AAV-h-AP1S3-shRNA
Cat No: shAAV-201087
Availability: 6-8 weeks
AAV-h-AP2A1-shRNA
Cat No: shAAV-201089
Availability: 4-5 weeks
AAV-h-AP2A2-shRNA
Cat No: shAAV-201090
Availability: 4-5 weeks
AAV-h-AP2B1-shRNA
Cat No: shAAV-201091
Availability: 6-8 weeks
AAV-h-AP2M1-shRNA
Cat No: shAAV-201093
Availability: 4-5 weeks
AAV-h-AP2S1-shRNA
Cat No: shAAV-201095
Availability: 4-5 weeks
AAV-h-AP3B1-shRNA
Cat No: shAAV-201096
Availability: 4-5 weeks
AAV-h-AP3B2-shRNA
Cat No: shAAV-201099
Availability: 6-8 weeks
AAV-h-AP3D1-shRNA
Cat No: shAAV-201100
Availability: 4-5 weeks
AAV-h-AP3M1-shRNA
Cat No: shAAV-201101
Availability: 4-5 weeks
AAV-h-AP3M2-shRNA
Cat No: shAAV-201104
Availability: 4-5 weeks
AAV-h-AP3S1-shRNA
Cat No: shAAV-201105
Availability: 4-5 weeks
